Full Text
The Full Text of this article is available as a PDF (270.4 KB).
References
- 1. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman SA, Geller NL, Goldberg AD, Habib GB, Masters RG, Moisa RB, Mueller H, Pearce DJ, Pepine CJ, Sopko G, Steingart RM, Stone PH, Knatterud GL, Conti CR: Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 1995; 26: 594–605 [DOI] [PubMed] [Google Scholar]
- 2. Davies R, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko G, Pratt C, Deanfield J, Conti CR: Asymptomatic Cardiac Ischemia Pilot (ACIP) Study two‐year follow‐up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997; 95: 2037–2043 [DOI] [PubMed] [Google Scholar]
- 3. de Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, Delaye J: Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease: Insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol 1996; 28: 1103–1108 [DOI] [PubMed] [Google Scholar]
- 4. de Lorgeril S, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J: Mediterranean alpha‐linolenic acid‐rich diet in secondary prevention of coronary artery disease. Lancet 1994; 343: 1454–1459 [DOI] [PubMed] [Google Scholar]
- 5. Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S, Mohammad AN: Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: Results of one year follow up. Br Med J 1992; 304: 1015–1019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, Martin JL, Monjaud I, Salen P, Toubol P: Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr 1995; 61: 1360S–1367S [DOI] [PubMed] [Google Scholar]
- 7. Scandinavian Simvastatin Survival Study Group : Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389 [PubMed] [Google Scholar]
- 8. Sacks FM, Pfeffer MA, Moyé LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Chuan‐Ghuan W, Davis BR, Braunwald E, and the CARE Investigators : The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001–1009 [DOI] [PubMed] [Google Scholar]
- 9. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781–786 [DOI] [PubMed] [Google Scholar]
- 10. Campeau L, Knatterud GLMK, Domanski M, Hunninghake DB, White CW, Geller NL, Rosenberg Y, Herd A, Cocanougher MK, Dunn K, Farmer J, Foreyt J, Gregory K, Insull W, Jackson M, Kleiman N, Lewis R, Lloyd C, Maresh K, Matthew C, Minor S, Roberts R, Salmon A, Shackelford P: The effect of aggressive lowering of low‐density lipoprotein cholesterol levels and low‐dose anticoagulation on obstructive changes in saphenous‐vein coronaryartery bypass grafts. N Engl J Med 1997; 336: 153–162 [DOI] [PubMed] [Google Scholar]